PURPOSE: To develop quercetin-loaded phospholipid vesicles, namely liposomes and PEVs (Penetration Enhancer-containing Vesicles), and to investigate their efficacy on TPA-induced skin inflammation. METHODS: Vesicles were made from a mixture of phospholipids, quercetin and polyethylene glycol 400 (PEG), specifically added to increase drug solubility and penetration through the skin. Vesicle morphology and self-assembly were probed by Cryo-Transmission Electron Microscopy and Small/Wide Angle X-ray Scattering, as well as the main physico-chemical features by Light Scattering. The anti-inflammatory efficacy of quercetin nanovesicles was assessed in vivo on TPA-treated mice dorsal skin by the determination of two biomarkers: oedema formation and myeloperoxidase activity. The uptake of vesicles by 3T3 fibroblasts was also evaluated. RESULTS: Small spherical vesicles were produced. Their size and lamellarity was strongly influenced by the PEG content (0%, 5%, 10% v/v). The administration of vesicular quercetin on TPA-inflamed skin resulted in an amelioration of the tissue damage, with a noticeable attenuation of oedema and leukocyte infiltration, especially using 5% PEG-PEVs, as also confirmed by confocal microscopy. In vitro studies disclosed a massive uptake and diffusion of PEVs in dermal fibroblasts. CONCLUSIONS: The proposed approach based on quercetin vesicular formulations may be of value in the treatment of inflammatory skin disorders.
PURPOSE: To develop quercetin-loaded phospholipid vesicles, namely liposomes and PEVs (Penetration Enhancer-containing Vesicles), and to investigate their efficacy on TPA-induced skin inflammation. METHODS: Vesicles were made from a mixture of phospholipids, quercetin and polyethylene glycol 400 (PEG), specifically added to increase drug solubility and penetration through the skin. Vesicle morphology and self-assembly were probed by Cryo-Transmission Electron Microscopy and Small/Wide Angle X-ray Scattering, as well as the main physico-chemical features by Light Scattering. The anti-inflammatory efficacy of quercetin nanovesicles was assessed in vivo on TPA-treated mice dorsal skin by the determination of two biomarkers: oedema formation and myeloperoxidase activity. The uptake of vesicles by 3T3 fibroblasts was also evaluated. RESULTS: Small spherical vesicles were produced. Their size and lamellarity was strongly influenced by the PEG content (0%, 5%, 10% v/v). The administration of vesicular quercetin on TPA-inflamed skin resulted in an amelioration of the tissue damage, with a noticeable attenuation of oedema and leukocyte infiltration, especially using 5% PEG-PEVs, as also confirmed by confocal microscopy. In vitro studies disclosed a massive uptake and diffusion of PEVs in dermal fibroblasts. CONCLUSIONS: The proposed approach based on quercetin vesicular formulations may be of value in the treatment of inflammatory skin disorders.
Authors: Abhijit A Date; Mangal S Nagarsenker; Shilpa Patere; Vivek Dhawan; R P Gude; P A Hassan; V Aswal; Frank Steiniger; Jana Thamm; Alfred Fahr Journal: Mol Pharm Date: 2011-04-20 Impact factor: 4.939
Authors: M Manconi; C Caddeo; C Sinico; D Valenti; M C Mostallino; S Lampis; M Monduzzi; A M Fadda Journal: Eur J Pharm Biopharm Date: 2012-08-13 Impact factor: 5.571
Authors: Pabyton G Cadena; Marcela A Pereira; Rafaela B S Cordeiro; Isabella M F Cavalcanti; Benício Barros Neto; Maria do Carmo C B Pimentel; José Luiz Lima Filho; Valdinete L Silva; Nereide S Santos-Magalhães Journal: Biochim Biophys Acta Date: 2012-10-25
Authors: Mogana Rajagopal; Alok K Paul; Ming-Tatt Lee; Anabelle Rose Joykin; Choo-Shiuan Por; Tooba Mahboob; Cristina C Salibay; Mario S Torres; Maria Melanie M Guiang; Mohammed Rahmatullah; Rownak Jahan; Khoshnur Jannat; Polrat Wilairatana; Maria de Lourdes Pereira; Chooi Ling Lim; Veeranoot Nissapatorn Journal: Plants (Basel) Date: 2022-05-08
Authors: Mohammed Elmowafy; Arafa Musa; Taghreed S Alnusaire; Khaled Shalaby; Maged M A Fouda; Ayman Salama; Mohammad M Al-Sanea; Mohamed A Abdelgawad; Mohammed Gamal; Shahinaze A Fouad Journal: Polymers (Basel) Date: 2021-05-31 Impact factor: 4.329